GB0808537D0 - Compositions - Google Patents

Compositions

Info

Publication number
GB0808537D0
GB0808537D0 GBGB0808537.5A GB0808537A GB0808537D0 GB 0808537 D0 GB0808537 D0 GB 0808537D0 GB 0808537 A GB0808537 A GB 0808537A GB 0808537 D0 GB0808537 D0 GB 0808537D0
Authority
GB
United Kingdom
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0808537.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Archimedes Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39571149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0808537(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Archimedes Development Ltd filed Critical Archimedes Development Ltd
Priority to GBGB0808537.5A priority Critical patent/GB0808537D0/en
Publication of GB0808537D0 publication Critical patent/GB0808537D0/en
Priority to CN2009801272725A priority patent/CN102088962B/zh
Priority to HK11112978.8A priority patent/HK1158510B/xx
Priority to DK09746033.1T priority patent/DK2278958T3/da
Priority to EP09746033.1A priority patent/EP2278958B1/en
Priority to US12/992,182 priority patent/US8491932B2/en
Priority to PCT/GB2009/001150 priority patent/WO2009138716A1/en
Priority to ES09746033.1T priority patent/ES2452265T3/es
Priority to JP2011508995A priority patent/JP5608641B2/ja
Priority to PL09746033T priority patent/PL2278958T3/pl
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0808537.5A 2008-05-12 2008-05-12 Compositions Ceased GB0808537D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0808537.5A GB0808537D0 (en) 2008-05-12 2008-05-12 Compositions
PL09746033T PL2278958T3 (pl) 2008-05-12 2009-05-07 Kompozycje do doustnego dostarczania kortykosteroidów
JP2011508995A JP5608641B2 (ja) 2008-05-12 2009-05-07 副腎皮質ステロイドの経口送達のための組成物
DK09746033.1T DK2278958T3 (da) 2008-05-12 2009-05-07 Sammensætninger til oral frigivelse af kortikosteroider
HK11112978.8A HK1158510B (en) 2008-05-12 2009-05-07 Compositions for the oral delivery of corticosteroids
CN2009801272725A CN102088962B (zh) 2008-05-12 2009-05-07 用于皮质类固醇口服给药的组合物
EP09746033.1A EP2278958B1 (en) 2008-05-12 2009-05-07 Compositions for the oral delivery of corticosteroids
US12/992,182 US8491932B2 (en) 2008-05-12 2009-05-07 Compositions for the oral delivery of corticosteroids
PCT/GB2009/001150 WO2009138716A1 (en) 2008-05-12 2009-05-07 Compositions for the oral delivery of corticosteroids
ES09746033.1T ES2452265T3 (es) 2008-05-12 2009-05-07 Composiciones para la administración oral de corticosteroides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0808537.5A GB0808537D0 (en) 2008-05-12 2008-05-12 Compositions

Publications (1)

Publication Number Publication Date
GB0808537D0 true GB0808537D0 (en) 2008-06-18

Family

ID=39571149

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0808537.5A Ceased GB0808537D0 (en) 2008-05-12 2008-05-12 Compositions

Country Status (9)

Country Link
US (1) US8491932B2 (enExample)
EP (1) EP2278958B1 (enExample)
JP (1) JP5608641B2 (enExample)
CN (1) CN102088962B (enExample)
DK (1) DK2278958T3 (enExample)
ES (1) ES2452265T3 (enExample)
GB (1) GB0808537D0 (enExample)
PL (1) PL2278958T3 (enExample)
WO (1) WO2009138716A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2419443C1 (ru) * 2009-12-08 2011-05-27 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ лечения больных язвенным колитом
JOP20200144A1 (ar) 2012-04-30 2017-06-16 Tillotts Pharma Ag تركيبة عقار ذو إطلاق متأخر
NZ717159A (en) 2013-10-29 2019-06-28 Tillotts Pharma Ag A delayed release drug formulation
CN104257669A (zh) * 2014-09-25 2015-01-07 合肥平光制药有限公司 一种用于向肠道递送水杨酸类药物的口服给药组合物
RU2018111690A (ru) 2015-09-11 2019-10-11 Сан Фармасьютикл Индастриз Лтд. Пероральная лекарственная форма будесонида
EP3257501A1 (en) * 2016-06-14 2017-12-20 Tillotts Pharma AG Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
WO2018111329A1 (en) * 2016-12-14 2018-06-21 Progenity Inc. Methods and ingestible devices for the regio-specific release of il-1 inhibitors at the site of gastrointestinal tract disease
CA3046023A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
EP3641734A4 (en) * 2017-06-23 2021-03-17 Sun Pharma Advanced Research Company Limited ANTI-ABUSE ORAL SOLID DOSAGE FORM
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
CN110200947A (zh) * 2019-06-27 2019-09-06 深圳市泛谷药业股份有限公司 一种安非他酮肠溶缓释微丸胶囊及其制备方法
CN112999229B (zh) * 2019-12-19 2023-01-24 江苏恒瑞医药股份有限公司 一种包含布地奈德的口服药物组合物
CN117157079A (zh) * 2021-04-20 2023-12-01 江苏恒瑞医药股份有限公司 一种口服肠溶皮质类固醇的药物组合物
EP4327806A4 (en) 2021-04-20 2024-10-23 Jiangsu Hengrui Pharmaceuticals Co., Ltd. CAPSULE FOR SPECIFIC MEDICATION DELIVERY AND MANUFACTURING PROCESS THEREFOR
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
EP4554566A1 (en) 2022-07-15 2025-05-21 Synthon B.V. Budesonide two layers capsule formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123403A (en) 1977-06-27 1978-10-31 The Dow Chemical Company Continuous process for preparing aqueous polymer microsuspensions
US4502888A (en) 1982-12-13 1985-03-05 The Dow Chemical Company Aqueous dispersions of plasticized polymer particles
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5142906A (en) * 1990-07-09 1992-09-01 Westinghouse Electric Corp. Apparatus for measuring valve stem loads in a motor operated valve assembly
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
GB9722426D0 (en) 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
ITRM20010614A1 (it) 2001-10-16 2003-04-16 Italchimici S P A Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.
JP2003201256A (ja) * 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
DE10214002A1 (de) 2002-03-27 2003-10-09 Roehm Gmbh Pharmazeutische Formulierung für den Wirkstoff Budesonid
AR041873A1 (es) 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
EP2231129A4 (en) * 2007-12-17 2013-01-30 Zalicus Inc THERAPEUTIC REGIMES FOR THE TREATMENT OF IMMUNO-INFLAMMATORY DISORDERS

Also Published As

Publication number Publication date
JP2011519967A (ja) 2011-07-14
CN102088962A (zh) 2011-06-08
CN102088962B (zh) 2013-07-31
JP5608641B2 (ja) 2014-10-15
EP2278958A1 (en) 2011-02-02
PL2278958T3 (pl) 2014-05-30
HK1158510A1 (en) 2012-07-20
DK2278958T3 (da) 2014-01-20
WO2009138716A1 (en) 2009-11-19
EP2278958B1 (en) 2014-01-01
ES2452265T3 (es) 2014-03-31
US20110104269A1 (en) 2011-05-05
US8491932B2 (en) 2013-07-23

Similar Documents

Publication Publication Date Title
SI2634232T1 (sl) Sestavki
GB0810404D0 (en) Compositions
ZA201103926B (en) Stable sulfoximine-insecticide compositions
GB0812041D0 (en) Compositions
GB0810554D0 (en) Herbicde composition
GB0808537D0 (en) Compositions
GB0801119D0 (en) Composition
GB0818804D0 (en) Compositions
GB0809808D0 (en) Composition
GB0811743D0 (en) Composition
GB0801401D0 (en) Composition
GB0810359D0 (en) Composition
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
GB0813589D0 (en) Composition
GB0809983D0 (en) Composition
GB0804031D0 (en) Composition
GB0814101D0 (en) Composition
GB0813165D0 (en) Composition
GB0822112D0 (en) Compositions
GB0809354D0 (en) Compositions
GB0805099D0 (en) Claening compositions
GB0818050D0 (en) Compositions
GB0800412D0 (en) Compositions
GB0812197D0 (en) Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)